Mankind Pharma makes investment in Actimed Therapeutics

18 Dec 2023 Evaluate

Mankind Pharma has made investment of British pound sterling 999,900 in Actimed Therapeutics (Actimed) on December 15, 2023. It is a strategic investment in the field of treatment of cancer cachexia, amyotrophic lateral sclerosis and other muscle wasting disorders. Post this investment the aggregate shareholding of the Company in Actimed will be around 10.19%.

Mankind Pharma is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products.

Mankind Pharma Share Price

2123.90 6.05 (0.29%)
20-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.00
Dr. Reddys Lab 1166.90
Cipla 1377.85
Zydus Lifesciences 872.95
Lupin 2166.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×